Published in Antimicrob Agents Chemother on March 01, 2003
Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results. J Clin Microbiol (2004) 1.40
New lnu(C) gene conferring resistance to lincomycin by nucleotidylation in Streptococcus agalactiae UCN36. Antimicrob Agents Chemother (2005) 1.11
Erythromycin resistance and genetic elements carrying macrolide efflux genes in Streptococcus agalactiae. Antimicrob Agents Chemother (2005) 1.03
Dominance of serotype Ia among group B Streptococci causing invasive infections in nonpregnant adults in Portugal. J Clin Microbiol (2012) 1.01
Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea. Antimicrob Agents Chemother (2004) 1.01
Phenotypic and genotypic characterization of group B streptococcal isolates in southern Brazil. J Clin Microbiol (2010) 0.98
In vitro activities of tigecycline against erythromycin-resistant Streptococcus pyogenes and Streptococcus agalactiae: mechanisms of macrolide and tetracycline resistance. Antimicrob Agents Chemother (2004) 0.95
Multicenter study of the mechanisms of resistance and clonal relationships of Streptococcus agalactiae isolates resistant to macrolides, lincosamides, and ketolides in Spain. Antimicrob Agents Chemother (2005) 0.95
Antibiotic susceptibility in neonatal invasive isolates of Streptococcus agalactiae in a 2-year nationwide surveillance study in Germany. Antimicrob Agents Chemother (2004) 0.94
Serotypes and genotypes of erythromycin-resistant group B streptococci in Korea. J Clin Microbiol (2004) 0.88
Correlation of serotypes and genotypes of macrolide-resistant Streptococcus agalactiae. Yonsei Med J (2005) 0.84
Serotypes, antibiotic susceptibilities, and multi-locus sequence type profiles of Streptococcus agalactiae isolates circulating in Beijing, China. PLoS One (2015) 0.83
Telithromycin susceptibility and genomic diversity of macrolide-resistant serotype III group B streptococci isolated in perinatal infections. Antimicrob Agents Chemother (2004) 0.81
Risk factors associated with group B streptococcus resistant to clindamycin and erythromycin in pregnant korean women. Infect Chemother (2013) 0.79
Epidemiology of Invasive Group B Streptococcal Disease in Alberta, Canada, from 2003 to 2013. J Clin Microbiol (2016) 0.76
DNA microarray-based typing of Streptococcus agalactiae isolates. J Clin Microbiol (2014) 0.76
Prevalence of vancomycin-resistant enterococcus in prenatal screening cultures. J Clin Microbiol (2004) 0.75
Phenotypic and genotypic characterization of Streptococcus agalactiae in pregnant women. First study in a province of Argentina. Braz J Microbiol (2013) 0.75
Time-kill activity of the streptogramin NXL 103 against Gram-positive and -negative bacteria. Antimicrob Agents Chemother (2011) 0.75
Prenatal culture-based screening of Streptococcus agalactiae colonisation: resistance against erythromycin and clindamycin. Eur J Clin Microbiol Infect Dis (2006) 0.75
Molecular epidemiology and distribution of serotypes, genotypes, and antibiotic resistance genes of Streptococcus agalactiae clinical isolates from Guelma, Algeria and Marseille, France. Eur J Clin Microbiol Infect Dis (2015) 0.75
Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother (1996) 10.56
Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother (1993) 4.83
Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention. MMWR Recomm Rep (1996) 4.71
Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study--1996. Sentinel Health Unit Surveillance System Site Coordinators. J Infect Dis (2000) 2.41
Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother (2001) 2.30
Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin. Obstet Gynecol (1998) 2.13
Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998. Clin Infect Dis (2000) 2.10
Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob Agents Chemother (1998) 2.00
High incidence of erythromycin-resistant streptococci in Taiwan. Antimicrob Agents Chemother (1997) 1.97
Change in antibiotic resistance of group B streptococcus: impact on intrapartum management. Am J Obstet Gynecol (1999) 1.70
Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective. Antimicrob Agents Chemother (2001) 1.58
Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere. Am J Obstet Gynecol (2000) 1.53
High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. Antimicrob Agents Chemother (2001) 1.36
Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French multicenter study. Antimicrob Agents Chemother (2001) 1.34
Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci. Antimicrob Agents Chemother (1994) 1.27
In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species. Antimicrob Agents Chemother (2001) 1.27
Macrolide and tetracycline resistance and molecular relationships of clinical strains of Streptococcus agalactiae. Antimicrob Agents Chemother (2002) 1.10
Emerging erythromycin resistance among group B streptococci in Korea. Eur J Clin Microbiol Infect Dis (2001) 1.02
Serotyping and antimicrobial susceptibility of group B Streptococcus over an eight-year period in southern Taiwan. Eur J Clin Microbiol Infect Dis (2001) 0.98
Relative potency of telithromycin, azithromycin and erythromycin against recent clinical isolates of gram-positive cocci. Eur J Clin Microbiol Infect Dis (2001) 0.83
Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis (1999) 2.81
Activated conformations of very late activation integrins detected by a group of antibodies (HUTS) specific for a novel regulatory region (355-425) of the common beta 1 chain. J Biol Chem (1996) 2.72
Cadmium-induced changes in the growth and oxidative metabolism of pea plants. J Exp Bot (2001) 2.40
Induction of the SOS response by new 4-quinolones. J Antimicrob Chemother (1987) 2.31
A role for the E-cadherin cell-cell adhesion molecule during tumor progression of mouse epidermal carcinogenesis. J Cell Biol (1991) 2.18
Initiation of DNA replication at CpG islands in mammalian chromosomes. EMBO J (1998) 2.13
[Antimicrobial therapy in exacerbated chronic obstructive pulmonary disease]. Arch Bronconeumol (2002) 2.03
Membrane intermediates in the peptidoglycan metabolism of Escherichia coli: possible roles of PBP 1b and PBP 3. J Bacteriol (1992) 1.99
Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA. J Hosp Infect (1997) 1.64
Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis (1995) 1.64
Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study. Aliment Pharmacol Ther (2011) 1.63
Eosinophilic gastroenteritis: our recent experience: one-year experience of atypical onset of an uncommon disease. Scand J Gastroenterol (2001) 1.46
Postantibiotic effect of imipenem on gram-positive and gram-negative micro-organisms. J Antimicrob Chemother (1986) 1.46
[Human papillomavirus vaccines: a new challenge for pediatricians]. An Pediatr (Barc) (2006) 1.40
[The return of gram-positive bacteria]. Enferm Infecc Microbiol Clin (1993) 1.38
[Presentation of 2 cases of neuromuscular excitation associated with propofol]. Rev Esp Anestesiol Reanim (1993) 1.38
[Comparative study of pneumococcal bacteremia in patients with and without HIV infection]. Rev Clin Esp (1993) 1.36
[Use of antibiotics in exacerbated chronic obstructive pulmonary disease]. Aten Primaria (2001) 1.31
Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer. Colorectal Dis (2007) 1.31
Inhibition of nuclear factor kappaB activation by a virus-encoded IkappaB-like protein. J Biol Chem (1998) 1.30
Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci. Antimicrob Agents Chemother (2000) 1.28
Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci. Antimicrob Agents Chemother (1994) 1.27
Specificities of antibodies to native DNA. Scand J Rheumatol Suppl (1975) 1.24
The central nervous system and infection by Candida species. Diagn Microbiol Infect Dis (2000) 1.17
Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group: comparison with the activities of 14 other agents. Antimicrob Agents Chemother (1999) 1.12
Comparison of epidemiological markers of Salmonella strains isolated from different sources in Spain. J Clin Microbiol (1992) 1.10
Antibiotic resistance surveillance of Stenotrophomonas maltophilia, 1993-1999. J Antimicrob Chemother (2001) 1.10
Towards an operational system for oil-spill forecast over Spanish waters: initial developments and implementation test. Mar Pollut Bull (2008) 1.07
Antibiotic susceptibility of group A streptococci: a 6-year follow-up study. Antimicrob Agents Chemother (1993) 1.06
Melatonin versus vitamin E as protective treatment against oxidative stress after extra-hepatic bile duct ligation in rats. J Pineal Res (2001) 1.06
The three-dimensional structure of the native ternary complex of bovine pancreatic procarboxypeptidase A with proproteinase E and chymotrypsinogen C. EMBO J (1995) 1.06
Effects of three features of a job-exposure matrix on risk estimates. Epidemiology (1994) 1.04
Improved cardiac function in patients with obstructive jaundice after internal biliary drainage: hemodynamic and hormonal assessment. Ann Surg (2001) 1.01
Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue. J Pathol (1997) 1.01
Roles for redox regulation in leaf senescence of pea plants grown on different sources of nitrogen nutrition. J Exp Bot (2006) 1.01
111In-pentetreotide scintigraphy is superior to 123I-MIBG scintigraphy in the diagnosis and location of chemodectoma. Nucl Med Commun (1998) 1.00
A combination of tigecycline, colistin, and meropenem against multidrug-resistant Acinetobacter baumannii bacteremia in a renal transplant recipient: pharmacodynamic and microbiological aspects. Rev Esp Quimioter (2010) 0.99
Stereoselective inhibition of inducible cyclooxygenase by chiral nonsteroidal antiinflammatory drugs. J Clin Pharmacol (1996) 0.98
Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989. Eur J Clin Microbiol Infect Dis (1992) 0.97
Sexual reinforcement is blocked by infusion of naloxone into the medial preoptic area. Behav Neurosci (1993) 0.97
Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient. Clin Microbiol Infect (2011) 0.96
Transcriptional attenuation control of the tylosin-resistance gene tlrA in Streptomyces fradiae. Mol Microbiol (1994) 0.96
Frailty assessment based on wavelet analysis during quiet standing balance test. J Biomech (2011) 0.95
Endophthalmitis caused by Listeria monocytogenes. J Clin Microbiol (2001) 0.95
In vitro activities of tigecycline against erythromycin-resistant Streptococcus pyogenes and Streptococcus agalactiae: mechanisms of macrolide and tetracycline resistance. Antimicrob Agents Chemother (2004) 0.95
Wavelet analysis based on time-frequency information discriminate chronic ankle instability. Clin Biomech (Bristol, Avon) (2009) 0.95
True hermaphroditism and normal male external genitalia: a rare presentation. Acta Paediatr (1999) 0.94
In vitro activity of tigecycline against Bacteroides species. J Antimicrob Chemother (2005) 0.93
Alzheimer's disease and the cystatin C gene polymorphism: an association study. Neurosci Lett (2001) 0.93
[Incidence of invasive pneumococcal infection in children aged less than two years. The heptavalent pneumococcal conjugate vaccine. Situation in Spain]. An Esp Pediatr (2002) 0.92
Impact of the BACTEC NR system in detecting Candida fungemia. J Clin Microbiol (1990) 0.91
Predominance of gram-positive microorganisms as a cause of septicemia in patients with hematological malignancies. Infect Control Hosp Epidemiol (1994) 0.91
Aminoglycoside-modifying enzymes in clinical isolates harboring extended-spectrum beta-lactamases. Antimicrob Agents Chemother (1992) 0.91
Multidrug-resistant pneumococci (serotype 8) causing invasive disease in HIV+ patients. Clin Microbiol Infect (2011) 0.90
Superoxide radical generation in peroxisomal membranes: evidence for the participation of the 18 kDa integral membrane polypeptide. Free Radic Res (1997) 0.90
The impact of extremely high temperatures on mortality and mortality cost. Int J Environ Health Res (2014) 0.89
Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents. Antimicrob Agents Chemother (1990) 0.89
Aquatic degradation of triclosan and formation of toxic chlorophenols in presence of low concentrations of free chlorine. Anal Bioanal Chem (2005) 0.88
[Immunization schedule of the Spanish Association of Pediatrics: recommendations 2008]. An Pediatr (Barc) (2008) 0.88
In vitro activity of retapamulin against linezolid and methicillin-resistant Staphylococcus aureus isolates. Rev Esp Quimioter (2011) 0.88
Cadmium toxicity and oxidative metabolism of pea leaf peroxisomes. Free Radic Res (1999) 0.88
Antibiotic inactivating enzymes from a clinical isolate of Agrobacterium radiobacter. J Antimicrob Chemother (1989) 0.88
Conditioned place preference produced by infusion of Met-enkephalin into the medial preoptic area. Brain Res (1991) 0.88
Severe hypersensitivity reaction to minocycline. J Investig Allergol Clin Immunol (2000) 0.87
Multiple cell cycle regulator alterations in Richter's transformation of chronic lymphocytic leukemia. Leukemia (2002) 0.87
Levels and risk assessment for humans and ecosystems of platinum-group elements in the airborne particles and road dust of some European cities. Sci Total Environ (2002) 0.86
Ebstein's anomaly, atrial paralysis and atrio-ventricular block: an uncommon association. Europace (2002) 0.86
Cytomegalovirus colitis mimicking a colonic neoplasm or ischemic colitis 4 years after heart transplantation. Transplantation (1998) 0.86
Incidence of erythromycin resistance in Streptococcus pyogenes: a 10-year study. Diagn Microbiol Infect Dis (1999) 0.86
Platinum and rhodium distribution in airborne particulate matter and road dust. Sci Total Environ (2001) 0.86
Recombinant gamma-interferon as adjuvant to hepatitis B vaccine in hemodialysis patients. Hepatology (1990) 0.85
Tumour necrosis factor-alpha inhibits synthesis of surfactant by isolated human type II pneumocytes. Eur J Surg (1993) 0.85
Increased levels of peroxisomal active oxygen-related enzymes in copper-tolerant pea plants. Plant Physiol (1987) 0.85
Biochemical and molecular effects of chronic haloperidol administration on brain and muscle mitochondria of rats. J Neurosci Res (1998) 0.85
[Bacteremia by Staphylococcus aureus: analysis of 311 episodes]. Enferm Infecc Microbiol Clin (1999) 0.85
Polymorphisms of pro-inflammatory cytokine genes and the risk for acute suppurative or chronic nonsuppurative apical periodontitis in a Colombian population. Int Endod J (2012) 0.84
[Motor neuron disease and HIV]. Rev Neurol (1997) 0.84
Reversal of cardiac cirrhosis following orthotopic heart transplantation. Am J Transplant (2008) 0.84
Autoantibodies to cryptic epitopes of C-reactive protein and other acute phase proteins in the toxic oil syndrome. J Autoimmun (1995) 0.84
Distribution of mef(A) and erm(B) genes in macrolide-resistant blood isolates of viridans group streptococci. J Antimicrob Chemother (2001) 0.83
Comparative activity of linezolid and other new agents against methicillin-resistant Staphylococcus aureus and teicoplanin-intermediate coagulase-negative staphylococci. J Antimicrob Chemother (2001) 0.83